BONEX — BoneSupport Holding AB Income Statement
0.000.00%
Last trade - 00:00- SEK17.16bn
- SEK16.86bn
- SEK898.73m
Annual income statement for BoneSupport Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 181 | 213 | 329 | 591 | 899 |
| Cost of Revenue | |||||
| Gross Profit | 162 | 190 | 298 | 541 | 832 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 279 | 294 | 393 | 577 | 733 |
| Operating Profit | -98.6 | -80.7 | -64.5 | 13.9 | 166 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -99 | -81.8 | -64.7 | 15.7 | 173 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -101 | -85.5 | -68.2 | 245 | 134 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -101 | -85.5 | -68.2 | 245 | 134 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -101 | -85.5 | -68.2 | 245 | 134 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.72 | -1.34 | -1.06 | 3.74 | 2.01 |
| Dividends per Share |